News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
615,648 Results
Type
Article (61088)
Company Profile (106)
Press Release (554448)
Multimedia
Podcasts (115)
Webinars (22)
Section
Business (171110)
Career Advice (2256)
Deals (25878)
Drug Delivery (92)
Drug Development (71148)
Employer Resources (150)
FDA (15779)
Job Trends (12978)
News (291749)
Policy (30374)
Tag
Academia (2928)
Academic (2)
Accelerated approval (17)
Adcomms (21)
Allergies (130)
Alliances (46690)
ALS (133)
Alzheimer's disease (1561)
Antibody-drug conjugate (ADC) (208)
Approvals (15932)
Artificial intelligence (437)
Autoimmune disease (94)
Automation (28)
Bankruptcy (227)
Best Places to Work (10195)
BIOSECURE Act (15)
Biosimilars (125)
Biotechnology (74)
Bladder cancer (121)
Brain cancer (49)
Breast cancer (480)
Cancer (3784)
Cardiovascular disease (304)
Career advice (1916)
Career pathing (32)
CAR-T (216)
CDC (38)
Cell therapy (595)
Cervical cancer (28)
Clinical research (59166)
Collaboration (1355)
Compensation (357)
Complete response letters (38)
COVID-19 (2651)
CRISPR (77)
C-suite (526)
Cystic fibrosis (127)
Data (4792)
Decentralized trials (2)
Denatured (41)
Depression (98)
Diabetes (392)
Diagnostics (5594)
Digital health (33)
Diversity (8)
Diversity, equity & inclusion (40)
Drug discovery (208)
Drug pricing (133)
Drug shortages (21)
Duchenne muscular dystrophy (180)
Earnings (71611)
Editorial (49)
Employer branding (20)
Employer resources (134)
Events (85964)
Executive appointments (792)
FDA (18362)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (4)
Frontotemporal dementia (18)
Funding (1120)
Gene editing (158)
Generative AI (42)
Gene therapy (471)
GLP-1 (812)
Government (4475)
Grass and pollen (8)
Guidances (363)
Healthcare (16276)
HIV (42)
Huntington's disease (30)
IgA nephropathy (58)
Immunology and inflammation (166)
Immuno-oncology (18)
Indications (65)
Infectious disease (2856)
Inflammatory bowel disease (155)
Inflation Reduction Act (14)
Influenza (88)
Intellectual property (170)
Interviews (413)
IPO (11896)
IRA (49)
Job creations (3119)
Job search strategy (1599)
Kidney cancer (10)
Labor market (67)
Layoffs (445)
Leadership (30)
Legal (6317)
Liver cancer (76)
Longevity (11)
Lung cancer (525)
Lymphoma (282)
Machine learning (31)
Management (50)
Manufacturing (539)
MASH (140)
Medical device (10679)
Medtech (10706)
Mergers & acquisitions (14763)
Metabolic disorders (947)
Multiple sclerosis (123)
NASH (14)
Neurodegenerative disease (217)
Neuropsychiatric disorders (49)
Neuroscience (2490)
NextGen: Class of 2025 (5539)
Non-profit (4657)
Now hiring (43)
Obesity (405)
Opinion (259)
Ovarian cancer (139)
Pain (140)
Pancreatic cancer (156)
Parkinson's disease (225)
Partnered (28)
Patents (349)
Patient recruitment (298)
Peanut (58)
People (47786)
Pharmaceutical (23)
Pharmacy benefit managers (17)
Phase I (17961)
Phase II (25304)
Phase III (20434)
Pipeline (3193)
Policy (238)
Postmarket research (2714)
Preclinical (8614)
Press Release (69)
Prostate cancer (208)
Psychedelics (36)
Radiopharmaceuticals (230)
Rare diseases (590)
Real estate (5110)
Recruiting (62)
Regulatory (23064)
Reports (39)
Research institute (2632)
Resumes & cover letters (355)
Rett syndrome (20)
RNA editing (10)
RSV (58)
Schizophrenia (121)
Series A (172)
Series B (119)
Service/supplier (12)
Sickle cell disease (71)
Special edition (22)
Spinal muscular atrophy (154)
Sponsored (37)
Startups (2891)
State (1)
Stomach cancer (11)
Supply chain (73)
Tariffs (54)
The Weekly (73)
Vaccines (902)
Venture capital (45)
Weight loss (258)
Women's health (53)
Worklife (17)
Date
Last 7 days (299)
Last 30 days (2527)
Last 365 days (26043)
2025 (24268)
2024 (29531)
2023 (33722)
2022 (44607)
2021 (48021)
2020 (46558)
2019 (40735)
2018 (30935)
2017 (28437)
2016 (28231)
2015 (32909)
2014 (26987)
2013 (24098)
2012 (24437)
2011 (24479)
2010 (23170)
Location
Africa (884)
Alabama (76)
Alaska (6)
Arizona (206)
Arkansas (10)
Asia (36675)
Australia (6601)
California (8063)
Canada (2550)
China (828)
Colorado (359)
Connecticut (390)
Delaware (238)
Europe (85412)
Florida (1310)
Georgia (281)
Hawaii (1)
Idaho (45)
Illinois (646)
India (48)
Indiana (411)
Iowa (19)
Japan (322)
Kansas (106)
Kentucky (30)
Louisiana (17)
Maine (38)
Maryland (1118)
Massachusetts (5878)
Michigan (283)
Minnesota (417)
Mississippi (4)
Missouri (95)
Montana (21)
Nebraska (22)
Nevada (87)
New Hampshire (61)
New Jersey (2488)
New Mexico (30)
New York (2325)
North Carolina (1233)
North Dakota (7)
Northern California (3764)
Ohio (236)
Oklahoma (18)
Oregon (27)
Pennsylvania (1666)
Puerto Rico (13)
Rhode Island (38)
South America (1146)
South Carolina (40)
South Dakota (1)
Southern California (3211)
Tennessee (138)
Texas (1235)
United States (30011)
Utah (260)
Vermont (1)
Virginia (206)
Washington D.C. (70)
Washington State (711)
West Virginia (3)
Wisconsin (81)
Wyoming (2)
615,648 Results for "food allergy research and education".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
RAPT Therapeutics Initiates prestIgE Phase 2b Clinical Trial of Ozureprubart (RPT904) in Patients with Food Allergies
October 28, 2025
·
7 min read
Press Releases
NEW SINGAPORE STUDY TO ASSESS GROWING PREVALENCE AND IMPACT OF FOOD ALLERGIES
June 27, 2025
·
13 min read
Immunology and inflammation
First Head-to-Head Study Cements Roche’s Xolair as Food Allergy Leader
Roche’s asthma drug Xolair appears to be safer and more effective than oral immunotherapy at treating adults and children with one or more food allergies.
March 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
RAPT Therapeutics Announces FDA Clearance of IND Application to Proceed to Phase 2b Trial of RPT904 in Food Allergy
September 29, 2025
·
5 min read
Press Releases
Children’s Hospital of Philadelphia Researchers Lead First Study to Identify Molecular Basis of Food Allergy
February 5, 2025
·
4 min read
Press Releases
Recently Discovered Immune Cell Type Is Key to Understanding Food Allergies
April 15, 2025
·
4 min read
Press Releases
Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm™ (epinephrine) Sublingual Film at the CFAAR Food Allergy Summit
June 25, 2025
·
8 min read
Allergies
Regeneron’s Antibodies Block Cat and Birch Allergies With ‘Robust Activity’
Regeneron’s antibody duos significantly lowered eye itching and redness, as well as pin prick reactivity, in people with cat and birch allergies. Still, BMO Capital Markets expressed uncertainty about the assets’ “commercial potential in a highly generic market.”
September 9, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Regeneron Advances Allergy Pipeline with Two Positive Phase 3 Trials Evaluating First-in-Class Antibody-Blockers of Cat and Birch Allergies
September 8, 2025
·
14 min read
Press Releases
Thermo Fisher Scientific Launches Industry-First Orbitrap Mass Detector for Environmental and Food Safety Testing
October 24, 2025
·
3 min read
1 of 61,565
Next
